These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 358777)

  • 41. Dopamine agonists: structure-activity relationships.
    Cannon JG
    Prog Drug Res; 1985; 29():303-414. PubMed ID: 3911262
    [No Abstract]   [Full Text] [Related]  

  • 42. A new semisynthetic ergot peptide alkaloid: DCN 203-922.
    Giger RK; Loosli HR; Walkinshaw MD; Clark BJ; Vigouret JM
    Experientia; 1987 Oct; 43(10):1125-30. PubMed ID: 2959497
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dopamine receptors and brain function.
    Jaber M; Robinson SW; Missale C; Caron MG
    Neuropharmacology; 1996; 35(11):1503-19. PubMed ID: 9025098
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dopamine receptors: from structure to function.
    Missale C; Nash SR; Robinson SW; Jaber M; Caron MG
    Physiol Rev; 1998 Jan; 78(1):189-225. PubMed ID: 9457173
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dopamine receptor pharmacology.
    Seeman P; Van Tol HH
    Trends Pharmacol Sci; 1994 Jul; 15(7):264-70. PubMed ID: 7940991
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gm527 deficiency in dentate gyrus improves memory through upregulating dopamine D1 receptor pathway.
    Jia J; Peng H; Tian R; Zhou H; Zheng H; Liu B; Lu Y
    CNS Neurosci Ther; 2023 Nov; 29(11):3290-3306. PubMed ID: 37248637
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cortical dopamine D5 receptors regulate neuronal circuit oscillatory activity and memory in rats.
    Albeely AM; Nolan CJ; Rasmussen DJ; Bailey CDC; Perreault ML
    CNS Neurosci Ther; 2023 Sep; 29(9):2469-2480. PubMed ID: 37076975
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dopamine D2-Subtype Receptors Outside the Blood-Brain Barrier Mediate Enhancement of Mesolimbic Dopamine Release and Conditioned Place Preference by Intravenous Dopamine.
    Obray JD; Small CA; Baldwin EK; Jang EY; Lee JG; Yang CH; Yorgason JT; Steffensen SC
    Front Cell Neurosci; 2022; 16():944243. PubMed ID: 35903367
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Understanding the role of dopamine in cancer: past, present and future.
    Grant CE; Flis AL; Ryan BM
    Carcinogenesis; 2022 Jun; 43(6):517-527. PubMed ID: 35616105
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Receptor-Mediated AKT/PI3K Signalling and Behavioural Alterations in Zebrafish Larvae Reveal Association between Schizophrenia and Opioid Use Disorder.
    Thiagarajan SK; Mok SY; Ogawa S; Parhar IS; Tang PY
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563106
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The organic cation transporter 2 regulates dopamine D1 receptor signaling at the Golgi apparatus.
    Puri NM; Romano GR; Lin TY; Mai QN; Irannejad R
    Elife; 2022 Apr; 11():. PubMed ID: 35467530
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Class A and C GPCR Dimers in Neurodegenerative Diseases.
    Caniceiro AB; Bueschbell B; Schiedel AC; Moreira IS
    Curr Neuropharmacol; 2022; 20(11):2081-2141. PubMed ID: 35339177
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Aversion Function of the Limbic Dopaminergic Neurons and Their Roles in Functional Neurological Disorders.
    He Z; Jiang Y; Gu S; Wu D; Qin D; Feng G; Ma X; Huang JH; Wang F
    Front Cell Dev Biol; 2021; 9():713762. PubMed ID: 34616730
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of dopamine receptors in lymphocytes and their changes in schizophrenia.
    Penedo MA; Rivera-Baltanás T; Pérez-Rodríguez D; Allen J; Borrajo A; Alonso-Crespo D; Fernández-Pereira C; Nieto-Araujo M; Ramos-García S; Barreiro-Villar C; Caruncho HJ; Olivares JM; Agís-Balboa RC
    Brain Behav Immun Health; 2021 Mar; 12():100199. PubMed ID: 34589732
    [TBL] [Abstract][Full Text] [Related]  

  • 55. History of the dopamine hypothesis of antipsychotic action.
    Seeman MV
    World J Psychiatry; 2021 Jul; 11(7):355-364. PubMed ID: 34327128
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ligand recognition and allosteric regulation of DRD1-Gs signaling complexes.
    Xiao P; Yan W; Gou L; Zhong YN; Kong L; Wu C; Wen X; Yuan Y; Cao S; Qu C; Yang X; Yang CC; Xia A; Hu Z; Zhang Q; He YH; Zhang DL; Zhang C; Hou GH; Liu H; Zhu L; Fu P; Yang S; Rosenbaum DM; Sun JP; Du Y; Zhang L; Yu X; Shao Z
    Cell; 2021 Feb; 184(4):943-956.e18. PubMed ID: 33571432
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structure of the dopamine D
    Im D; Inoue A; Fujiwara T; Nakane T; Yamanaka Y; Uemura T; Mori C; Shiimura Y; Kimura KT; Asada H; Nomura N; Tanaka T; Yamashita A; Nango E; Tono K; Kadji FMN; Aoki J; Iwata S; Shimamura T
    Nat Commun; 2020 Dec; 11(1):6442. PubMed ID: 33353947
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Split Luciferase Complementation Assay for the Quantification of β-Arrestin2 Recruitment to Dopamine D
    Forster L; Grätz L; Mönnich D; Bernhardt G; Pockes S
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32847148
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Response of Ventral Tegmental Area Dopaminergic Neurons to Bupropion: Excitation or Inhibition?
    Sadighparvar S; Tale F; Shahabi P; Naderi S; Ghaderi Pakdel F
    Basic Clin Neurosci; 2019; 10(4):281-304. PubMed ID: 32231766
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dopamine-induced calcium signaling in olfactory bulb astrocytes.
    Fischer T; Scheffler P; Lohr C
    Sci Rep; 2020 Jan; 10(1):631. PubMed ID: 31959788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.